FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2159229077> ?p ?o ?g. }

• W2159229077 endingPage "1542" @default.
• W2159229077 startingPage "1539" @default.
• W2159229077 abstract "No AccessJournal of UrologyPediatric Urology1 Oct 1997POLYTETRAFLUOROETHYLENE GIANT GRANULOMA AND ADENOPATHY: LONG-TERM COMPLICATIONS FOLLOWING SUBURETERAL POLYTETRAFLUOROETHYLENE INJECTION FOR THE TREATMENT OF VESICOURETERAL REFLUX IN CHILDREN Francesco Aragona, Leonardo D'Urso, Enrico Scremin, Roberto Salmaso, and Giacomo Passerini Glazel Francesco AragonaFrancesco Aragona More articles by this author , Leonardo D'UrsoLeonardo D'Urso More articles by this author , Enrico ScreminEnrico Scremin More articles by this author , Roberto SalmasoRoberto Salmaso More articles by this author , and Giacomo Passerini GlazelGiacomo Passerini Glazel More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)64275-7AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: The use of polytetrafluoroethylene as bulking agent for the endoscopic treatment of vesicoureteral reflux in children has raised many concerns about the implant histocompatibility and the risk of migration of polytetrafluoroethylene particles. We report on 3 cases of long-term complications following subureteral polytetrafluoroethylene injection (STING) and an extensive review of the literature is presented. Materials and Methods: Between January 1993 and December 1995, 3 children (2 males, 1 female; 4, 7 and 6 years old), previously submitted to STING, underwent open surgery for recurrent vesicoureteral reflux. Results: In 1 case a hard nodular mass, strictly adherent to the ureteral wall, was a foreign body giant granuloma. All patients demonstrated a heavy multinucleated foreign body reaction around polytetrafluoroethylene particles in the pelvic nodes. Conclusions: Many experimental studies and some clinical observations have demonstrated that polytetrafluoroethylene particles elicit a foreign body granulomatous reaction and have the tendency to migrate. Until the long-term effects of their presence are well known, STING should be carefully evaluated in children and young patients. References 1 : Treatment of vesicoureteric reflux by endoscopic injection of polytetrafluoroethylene.. Br. Med. J.1984; 289: 7. Google Scholar 2 : Migration and granulomatous reaction after periurethral injection of Polytef (teflon).. J.A.M.A.1984; 251: 3277. Google Scholar 3 : Ten year experience with subureteric polytetrafluoroethylene (polytetrafluoroethylene) injection (STING) in the treatment of vesico-ureteric reflux.. Brit. J. Urol.1995; 75: 126. Google Scholar 4 : Ureteral lesions due to endoscopic treatment of vesicoureteral reflux by injection of polytetrafluoroethylene: pathological study.. Eur. Urol.1990; 17: 325. Google Scholar 5 : Correction of experimentally produced vesicoureteric reflux in the piglet by intravesical injection of polytetrafluoroethylene.. Brit. Med. J.1984; 289: 5. Google Scholar 6 : Endoscopic treatment of reflux: experimental study and review of polytetrafluoroethylene and collagen.. Eur. Urol.1993; 23: 386. Google Scholar 7 : Long-term effects of polytetrafluoroethylene injected into the rat bladder submucosa.. Urology1994; 43: 852. Google Scholar 8 : Histologic evaluation of polytetrafluoroethylene granulomas of human vocal cords: a light and electron microscopy study.. Acta Otolaryngol.1982; 93: 475. Google Scholar 9 : Polytetrafluoroethyleneomas of larynx and neck.. Hum. Pathol.1990; 21: 617. Google Scholar 10 : Vesicoureteral reflux in children: endoscopic treatment.. Eur. Urol.1990; 17: 314. Google Scholar 11 : Histological changes following submucosal polytetrafluoroethylene injection in the bladder.. J. Ped. Surg.1991; 26: 546. Google Scholar 12 : The STING: postoperative evaluation for granuloma development in the pediatric patient.. J. Urol.1988; 139: 186 A. part 2, abstract 93. Google Scholar 13 : Complete urinary obstruction following periurethral polytetrafluoroethylene injection for urinary incontinence.. J. Urol.1989; 141: 1199. Abstract, Google Scholar 14 : Uropatia obstructiva secundaria a inyeccion periurethral de pasta de teflon.. Arch. Esp. Urol.1989; 42: 571. Google Scholar 15 : Periurethral granuloma: unusual complication of polytetrafluoroethylene periurethral injection.. Urology1988; 31: 422. Google Scholar 16 : Diverticulo de uretra masculina secundario a inyeccion parauretral de teflon.. Arch. Esp. Urol.1987; 40: 291. Google Scholar 17 : Granulome periureteral apres injection de polytetrafluoroethylene pour reflux vesico-ureteral.. Prog. Urol.1991; 1: 1046. Google Scholar 18 : Fine-needle aspiration of a periurethral polytetrafluoroethylene-filled cyst following radical prostatectomy.. Diagn. Cytopath.1992; 8: 614. Google Scholar 19 : Bladder outlet obstruction after multiple periurethral polytetrafluoroethylene injections.. J. Urol.1995; 153: 149. Abstract, Google Scholar 20 : Bioplastique: a new textured copolymer microparticles promises permanence in soft-tissue augmentation.. Plast. Reconstr. Surg.1991; 87: 693. Google Scholar 21 : Polytetrafluoroethylene granuloma mimicking a thyroid tumor.. Diagn. Cytopathol.1987; 3: 156. Google Scholar 22 : Laryngeal tissue response to polytetrafluoroethylene.. Arch. Otolaryngol.1967; 86: 562. Google Scholar 23 : Endoscopic treatment of reflux: migration of polytetrafluoroethylene into the lungs and brain.. Eur. Urol.1993; 23: 394. Google Scholar 24 : Current status of the STING: an American perspective.. Brit. J. Urol.1995; 75: 121. Google Scholar 25 : Treatment of vesicoureteral reflux in children by endoscopic injection of polytetrafluoroethylene. Review of 2 years of experience.. Eur. Urol.1990; 17: 304. Google Scholar 26 : Silicone lymphadenopathy. A case report and review of the literature Amer.. J. Dermatopathol.1993; 15: 82. Google Scholar 27 : Particles found in lung and brain following subureteral injection of polyfluoroethylene paste are not polytetrafluoroethylene particles.. J. Urol.1994; 152: 636. Abstract, Google Scholar 28 : Polytetrafluoroethylene injection for urinary incontinence in children.. J. Urol.1985; 133: 248. Abstract, Google Scholar 29 : Transurethral polytetrafluoroethylene injection for post-prostatectomy urinary incontinence.. J. Urol.1984; 132: 463. Abstract, Google Scholar 30 : Endoscopic treatment of vesicoureteral reflux in children.. J. Urol.1987; 138: 950. Abstract, Google Scholar 31 : Pulmonary polytetrafluoroethylene granulomas following periurethral polytetrafluoroethylene injection for urinary incontinence. Letter to the Editor.. Arch. Path. Lab. Med.1983; 107: 611. Google Scholar 32 : Periurethral polytetrafluoroethylene injection for urinary incontinence.. J. Urol.1982; 127: 439. Link, Google Scholar 33 : Polytetrafluoroethylene injection in stress incontinence.. Brit. J. Urol.1985; 57: 78. Google Scholar 34 : Pulmonary problems associated with the use of polytetrafluoroethylene.. J. Occup. Med.1977; 19: 693. Google Scholar 35 : Pulmonary migration following periurethral polytetrafluoroethylene injection for urinary incontinence.. J. Urol.1989; 142: 821. Abstract, Google Scholar 36 : Multicenter survey of endoscopic treatment of vesicoureteral reflux in children.. Eur. Urol.1990; 17: 328. Google Scholar 37 : Effects of submucosal polytetrafluoroethylene paste injection in vesicoureteric reflux: results with 1- and 2-year follow-up data.. Eur. Urol.1993; 23: 379. Google Scholar 38 : Treatment of primary vesicoureteric reflux by polytetrafluoroethylene injection: a middle-term follow-up study.. Eur. Urol.1993; 23: 375. Google Scholar 39 : Endoscopic treatment of primary vesicoureteric reflux in infants by subureteric injection of polytetrafluoroethylene. A 9-year follow-up. Eur. Urol.1995; 27: 67. Google Scholar 40 : Subureteric polytetrafluoroethylene injection (STING). Results of a European survey.. Eur. Urol.1995; 27: 71. Google Scholar 41 : Brain injury in a healthy child one year after periureteral injection of polytetrafluoroethylene.. Pediatrics1996; 98: 290. Google Scholar From the Institutes of Urology and Pathology, University of Padua, Padua, Italy.© 1997 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited ByYücel S, Tarcan T and Şimşek F (2018) Durability of a Single Successful Endoscopic Polytetrafluoroethylene Injection for Primary Vesicoureteral Reflux: 14-Year Followup ResultsJournal of Urology, VOL. 178, NO. 1, (265-268), Online publication date: 1-Jul-2007.Elmore J, Kirsch A, Perez-Brayfield M, Scherz H and Koyle M (2018) Salvage Extravesical Ureteral Reimplantation After Failed Endoscopic Surgery for Vesicoureteral RefluxJournal of Urology, VOL. 176, NO. 3, (1158-1160), Online publication date: 1-Sep-2006.Pinto K, Pugach J and Saalfield J (2018) Lack of Usefulness of Positioned Instillation of Contrast Cystogram After Injection of Dextranomer/Hyaluronic AcidJournal of Urology, VOL. 176, NO. 6, (2654-2656), Online publication date: 1-Dec-2006.BEDİR S, KİLCİLER M, ÖZGÖK Y, DEVECİ G and ERDURAN D (2018) LONG-TERM COMPLICATION DUE TO DEXTRANOMER BASED IMPLANT: GRANULOMA CAUSING URINARY OBSTRUCTIONJournal of Urology, VOL. 172, NO. 1, (247-248), Online publication date: 1-Jul-2004.MADJAR S, COVINGTON-NICHOLS C and SECREST C (2018) New Periurethral Bulking Agent for Stress Urinary Incontinence: Modified Technique and Early ResultsJournal of Urology, VOL. 170, NO. 6, (2327-2329), Online publication date: 1-Dec-2003.Aragona F (2018) RE: ENDOSCOPIC TREATMENT OF VESICOURETERAL REFLUX: 11 TO 17 YEARS OF FOLLOWUPJournal of Urology, VOL. 168, NO. 6, (2554-2555), Online publication date: 1-Dec-2002. (2018) RE: ENDOSCOPIC TREATMENT OF VESICOURETERAL REFLUX: 11 TO 17 YEARS OF FOLLOWUPJournal of Urology, VOL. 168, NO. 6, (2555-2555), Online publication date: 1-Dec-2002.AL-HUNAYAN A, KEHINDE E, ELSALAM M and AL-MUKHTAR R (2018) Outcome of Endoscopic Treatment for Vesicoureteral Reflux in Children Using PolydimethylsiloxaneJournal of Urology, VOL. 168, NO. 5, (2181-2183), Online publication date: 1-Nov-2002.CHERTIN B, COLHOUN E, VELAYUDHAM M and PURI P (2018) ENDOSCOPIC TREATMENT OF VESICOURETERAL REFLUX: 11 TO 17 YEARS OF FOLLOWUPJournal of Urology, VOL. 167, NO. 3, (1443-1446), Online publication date: 1-Mar-2002.DIAMOND D and CALDAMONE A (2018) ENDOSCOPIC CORRECTION OF VESICOURETERAL REFLUX IN CHILDREN USING AUTOLOGOUS CHONDROCYTES: PRELIMINARY RESULTSJournal of Urology, VOL. 162, NO. 3 Part 2, (1185-1188), Online publication date: 1-Sep-1999.PURI P and GRANATA C (2018) MULTICENTER SURVEY OF ENDOSCOPIC TREATMENT OF VESICOURETERAL REFLUX USING POLYTETRAFLUOROETHYLENEJournal of Urology, VOL. 160, NO. 3 Part 2, (1007-1011), Online publication date: 1-Sep-1998. Volume 158Issue 4October 1997Page: 1539-1542 Advertisement Copyright & Permissions© 1997 by American Urological Association, Inc.MetricsAuthor Information Francesco Aragona More articles by this author Leonardo D'Urso More articles by this author Enrico Scremin More articles by this author Roberto Salmaso More articles by this author Giacomo Passerini Glazel More articles by this author Expand All Advertisement PDF DownloadLoading ..." @default.
• W2159229077 created "2016-06-24" @default.
• W2159229077 creator A5034266892 @default.
• W2159229077 creator A5046142763 @default.
• W2159229077 creator A5050256903 @default.
• W2159229077 creator A5076076478 @default.
• W2159229077 creator A5085365717 @default.
• W2159229077 date "1997-10-01" @default.
• W2159229077 modified "2023-10-17" @default.
• W2159229077 title "POLYTETRAFLUOROETHYLENE GIANT GRANULOMA AND ADENOPATHY: LONG-TERM COMPLICATIONS FOLLOWING SUBURETERAL POLYTETRAFLUOROETHYLENE INJECTION FOR THE TREATMENT OF VESICOURETERAL REFLUX IN CHILDREN" @default.
• W2159229077 cites W1126539 @default.
• W2159229077 cites W123358989 @default.
• W2159229077 cites W171198399 @default.
• W2159229077 cites W1968277667 @default.
• W2159229077 cites W1971606283 @default.
• W2159229077 cites W1991100147 @default.
• W2159229077 cites W1995074366 @default.
• W2159229077 cites W2002531289 @default.
• W2159229077 cites W2005739559 @default.
• W2159229077 cites W2035418981 @default.
• W2159229077 cites W2049240170 @default.
• W2159229077 cites W2082185267 @default.
• W2159229077 cites W2087229423 @default.
• W2159229077 cites W2089496361 @default.
• W2159229077 cites W2124317483 @default.
• W2159229077 cites W2138455687 @default.
• W2159229077 cites W2138541900 @default.
• W2159229077 cites W2149275449 @default.
• W2159229077 cites W231069055 @default.
• W2159229077 cites W2343615513 @default.
• W2159229077 cites W2395509025 @default.
• W2159229077 cites W2401763325 @default.
• W2159229077 cites W2407425564 @default.
• W2159229077 cites W2410513878 @default.
• W2159229077 cites W2415915883 @default.
• W2159229077 cites W2416040457 @default.
• W2159229077 cites W2419565888 @default.
• W2159229077 cites W2419613774 @default.
• W2159229077 cites W2422329061 @default.
• W2159229077 cites W2433098774 @default.
• W2159229077 cites W4252033292 @default.
• W2159229077 cites W69771 @default.
• W2159229077 cites W813304505 @default.
• W2159229077 cites W2041936796 @default.
• W2159229077 cites W2992089389 @default.
• W2159229077 doi "https://doi.org/10.1016/s0022-5347(01)64275-7" @default.
• W2159229077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9302169" @default.
• W2159229077 hasPublicationYear "1997" @default.
• W2159229077 type Work @default.
• W2159229077 sameAs 2159229077 @default.
• W2159229077 citedByCount "55" @default.
• W2159229077 countsByYear W21592290772012 @default.
• W2159229077 countsByYear W21592290772014 @default.
• W2159229077 countsByYear W21592290772015 @default.
• W2159229077 countsByYear W21592290772016 @default.
• W2159229077 countsByYear W21592290772017 @default.
• W2159229077 countsByYear W21592290772018 @default.
• W2159229077 countsByYear W21592290772020 @default.
• W2159229077 countsByYear W21592290772022 @default.
• W2159229077 countsByYear W21592290772023 @default.
• W2159229077 crossrefType "journal-article" @default.
• W2159229077 hasAuthorship W2159229077A5034266892 @default.
• W2159229077 hasAuthorship W2159229077A5046142763 @default.
• W2159229077 hasAuthorship W2159229077A5050256903 @default.
• W2159229077 hasAuthorship W2159229077A5076076478 @default.
• W2159229077 hasAuthorship W2159229077A5085365717 @default.
• W2159229077 hasConcept C126838900 @default.
• W2159229077 hasConcept C126894567 @default.
• W2159229077 hasConcept C141071460 @default.
• W2159229077 hasConcept C142724271 @default.
• W2159229077 hasConcept C191897082 @default.
• W2159229077 hasConcept C192562407 @default.
• W2159229077 hasConcept C2776664737 @default.
• W2159229077 hasConcept C2777609623 @default.
• W2159229077 hasConcept C2779134260 @default.
• W2159229077 hasConcept C2780140890 @default.
• W2159229077 hasConcept C2780557906 @default.
• W2159229077 hasConcept C43270747 @default.
• W2159229077 hasConcept C71924100 @default.
• W2159229077 hasConceptScore W2159229077C126838900 @default.
• W2159229077 hasConceptScore W2159229077C126894567 @default.
• W2159229077 hasConceptScore W2159229077C141071460 @default.
• W2159229077 hasConceptScore W2159229077C142724271 @default.
• W2159229077 hasConceptScore W2159229077C191897082 @default.
• W2159229077 hasConceptScore W2159229077C192562407 @default.
• W2159229077 hasConceptScore W2159229077C2776664737 @default.
• W2159229077 hasConceptScore W2159229077C2777609623 @default.
• W2159229077 hasConceptScore W2159229077C2779134260 @default.
• W2159229077 hasConceptScore W2159229077C2780140890 @default.
• W2159229077 hasConceptScore W2159229077C2780557906 @default.
• W2159229077 hasConceptScore W2159229077C43270747 @default.
• W2159229077 hasConceptScore W2159229077C71924100 @default.
• W2159229077 hasIssue "4" @default.
• W2159229077 hasLocation W21592290771 @default.
• W2159229077 hasLocation W21592290772 @default.
• W2159229077 hasOpenAccess W2159229077 @default.
• W2159229077 hasPrimaryLocation W21592290771 @default.
• W2159229077 hasRelatedWork W1964846374 @default.

• next